Bristol-Myers Squibb Aktie

Kaufen
Verkaufen
55,84 EUR +0,67 EUR +1,21 %
57,70 USD -0,30 USD -0,52 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 112,21 Mrd. EUR

KGV 13,29 Div. Rendite 4,50%

WKN 850501

ISIN US1101221083

Symbol BMY


Bristol-Myers Squibb Aktie Analyse

03.05.19 Bristol-Myers Squibb overweight Barclays Capital
07.12.18 Bristol-Myers Squibb Outperform BMO Capital Markets
27.04.18 Bristol-Myers Squibb Market Perform BMO Capital Markets
15.02.18 Bristol-Myers Squibb overweight Morgan Stanley
29.04.16 Bristol-Myers Squibb Buy UBS AG
27.02.15 Bristol-Myers Squibb Buy Argus Research Company
12.01.15 Bristol-Myers Squibb Buy Argus Research Company
17.10.14 Bristol-Myers Squibb Outperform BMO Capital Markets
12.09.12 Bristol-Myers Squibb buy Goldman Sachs Group Inc.
30.04.12 Bristol-Myers Squibb overweight Barclays Capital
30.01.12 Bristol-Myers Squibb overweight Barclays Capital
10.01.12 Bristol-Myers Squibb overweight Barclays Capital
08.11.11 Bristol-Myers Squibb buy Citigroup Corp.
31.10.11 Bristol-Myers Squibb overweight Barclays Capital
26.10.11 Bristol-Myers Squibb buy Citigroup Corp.
06.10.11 Bristol-Myers Squibb buy Banc of America Securities-Merrill Lynch
03.08.11 Bristol-Myers Squibb buy Citigroup Corp.
01.08.11 Bristol-Myers Squibb buy Citigroup Corp.
21.07.11 Bristol-Myers Squibb overweight Barclays Capital
20.07.11 Bristol-Myers Squibb buy Citigroup Corp.
12.07.11 Bristol-Myers Squibb buy Citigroup Corp.
24.06.11 Bristol-Myers Squibb buy Citigroup Corp.
24.06.11 Bristol-Myers Squibb buy Citigroup Corp.
24.06.11 Bristol-Myers Squibb overweight Barclays Capital
24.06.11 Bristol-Myers Squibb overweight Morgan Stanley
01.06.11 Bristol-Myers Squibb buy Citigroup Corp.
02.05.11 Bristol-Myers Squibb overweight Barclays Capital
19.04.11 Bristol-Myers Squibb overweight Barclays Capital
15.04.11 Bristol-Myers Squibb overweight Barclays Capital
07.04.11 Bristol-Myers Squibb overweight Barclays Capital
29.03.11 Bristol-Myers Squibb overweight Barclays Capital
29.03.11 Bristol-Myers Squibb buy Goldman Sachs Group Inc.
31.01.11 Bristol-Myers Squibb overweight Barclays Capital
10.01.11 Bristol-Myers Squibb buy Citigroup Corp.
22.11.10 Bristol-Myers Squibb overweight Barclays Capital
28.10.10 Bristol-Myers Squibb overweight Barclays Capital
21.10.10 Bristol-Myers Squibb overweight Barclays Capital
09.09.10 Bristol-Myers Squibb overweight Barclays Capital
31.08.10 Bristol-Myers Squibb buy Jefferies & Company Inc.
27.07.10 Bristol-Myers Squibb overweight Barclays Capital
16.07.10 Bristol-Myers Squibb kaufen Barclays Capital
30.04.10 Bristol-Myers Squibb kaufen Barclays Capital
15.04.10 Bristol-Myers Squibb kaufen Barclays Capital
05.03.10 Bristol-Myers Squibb kaufen Morgan Stanley
28.10.09 Bristol-Myers Squibb overweight Barclays Capital
16.07.09 Bristol-Myers Squibb overweight Morgan Stanley
01.06.09 Bristol-Myers Squibb buy UBS AG
07.05.09 Bristol-Myers Squibb Focus Money
02.04.09 Bristol-Myers Squibb buy UBS AG
09.02.09 Bristol-Myers Squibb Wirtschaftswoche